1641P Phase I/II trial of oral masofaniten (EPI-7386) in combination with enzalutamide (Enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Kyriakopoulos, C
  • Chatta, G
  • Laccetti, AL
  • Iannotti, N
  • Sokolova, AO
  • Hotte, Sebastien
  • Tutrone, R
  • Markowski, MC
  • Nordquist, LT
  • Pili, R
  • Saad, F
  • Zhang, J
  • Villaluna, K
  • Younginger, B
  • Le Moigne, R
  • Cesano, A

publication date

  • September 2024